Member Info for whimax

No, it didn’t. Might be some big late ones show up later or tomorrow night.

Good day tho (this and NFX are 2 biggies) It’s been a while lol.

That’s 3 times in less than 2 weeks that’s happened here.

It seemed odd the first time, I knew something was up the second time, I suspect I might regret not acting on it and buying more lol. Time will tell.

As per my post last week where we went into auction at 4.25 and didn’t come out again.......

Well that’s us in again. Will we come out before close??

Wouldn’t surprise me if both companies were taken out by Q1 2021.

In order to make the gains people must be prepared to put up with the volatility tho. There’s big bucks at stake here so you’re not going to just be handed it on a plate.
MM’s games already getting into people’s heads I see.

GL

Excellent posts Positivevibes. Thanks for sharing.

Enormous potential here (again), only this time around it comes without the risks involved in elephant hunting. This could easy double from here before next news.

Yip. They’ll need to take this nearer 5p on the bid to temp sellers imo. At least at that level, some who got in in mid September will be showing a 50% gain and might be tempted.
Even then, I wouldn’t be, with what’s to come in short term.

From 16th September RNS. It’s just a nominal amount for tax/HMRC purposes and has no bearing on actual value.

“ The Demerger will be implemented by Tiziana declaring a dividend in specie on the Tiziana Shares equal to the book value (of approximately £3.07m) of Tiziana's shareholding in StemPrintER Sciences, the entity within the Tiziana group which holds all of the assets and intellectual property relating to StemPrintER and SPARE and £1.0 million in cash.”

That was always the case Davey. It’s in the Demerger RNS.

MM’s still keeping the spread as wide as possible tho I see. Heaven forbid anyone thinks they are picking up a bargain, eh boys. ****s

ForFX, yesterday’s UT was at 3.36p (the one before the 1.6m one) on the list above. The 1.6m was defo a buy.

Shareholderchar. I’m expecting a slow and steady rise here from now. The last 2 weeks has seen an excellent consolation, it feels like there is an order being filled in the background and there are virtually no sellers at this level so it’s not taking much to nudge the price up.
The MCap is also tiny compared to assets value and a small number of value investors will be sufficient to keep this moving in the right direction imo.

Lol Chab. Now it makes sense. I should have known the reason you’re so miserable all the time is because you were a teuchter!! Lol.
Just kidding.

I ain’t gonna be happy if we get a speeding ticket!!

IG moved to “Closing Only”. Always make sure you can buy, before you sell.

Volume is quite small but it doesn’t look like there’s much to be had at these prices. Not many will be in any kind of real profit, and who in their right mind would sell now, especially after having held alll this time.
It’s felt for the last week or 2 as though there might be an order being filled under the radar. Time will tell I guess.

Agreed Goup. Success in Brazil and we’re looking at $1b+ excluding StemPrintER imo.

https://www.proactiveinvestors.co.uk/companies/news/929663/tiziana-life-sciences-expanding-the-pipeline-unlocking-value-929663.html

“Industry metrics suggest that the current market valuation of Tiziana does not fully reflect its underlying therapeutic pipeline and attributes no value to Accustem Sciences, even at a discount to the takeover multiple paid by EXAS. We suggest a target valuation of up to £700mln for its therapeutic programmes on executing milestones over the next 12-18 months, with Accustem providing pure upside to the current market valuation“

Which is my point JH. 3 weeks ago he was still completing the paperwork for export, so for you state that “trials were expected to start a few weeks ago” and that there has been “Further issues with exporting of Foralumab”, is, at best, mischief making.
There is also no guarantee that the commencement of trials will be RNS’d, although i suspect it will be.

I’m not seeing/picking up any Ramping from Professional. Almost the opposite in fact. He is hinting at delays and slippage (when there isn’t any at this point) whilst also stating he is looking to take a position this week.

No they were not JohnHenry. In the Bloomberg interview on 27th Dr Shailu said he was completing the paperwork required for the export of Foralumab.
There is no delay or “further issue” as so far, there have been no issues.